Bivatuzumab (BIWA 4), a humanized monoclonal antibody, targets the CD44v6 isoform, a variant of the CD44 standard form. This antibody has been specifically developed for its potential role in targeting CD44v6, which is implicated in the progression of various sarcomas. Bivatuzumab is utilized in research focusing on chimeric antigen receptor (CAR)-redirected cytokine-induced killer (CIK) cells, providing a promising therapeutic approach for sarcoma treatment.
Bivatuzumab (BIWA 4), a humanized monoclonal antibody, targets the CD44v6 isoform, a variant of the CD44 standard form. This antibody has been specifically developed for its potential role in targeting CD44v6, which is implicated in the progression of various sarcomas. Bivatuzumab is utilized in research focusing on chimeric antigen receptor (CAR)-redirected cytokine-induced killer (CIK) cells, providing a promising therapeutic approach for sarcoma treatment.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
